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Abstract
Conditional expression is a powerful tool to investigate the role of bacterial genes. Here, we
adapt the Pseudomonas putida-derived positively regulated XylS/Pm expression system to
control inducible gene expression inMycobacterium smegmatis andMycobacterium tuber-
culosis, the causative agent of human tuberculosis. By making simple changes to a Gram-
negative broad-host-range XylS/Pm-regulated gene expression vector, we prove that it is
possible to adapt this well-studied expression system to non-Gram-negative species. With
the benzoic acid-derived inducerm-toluate, we achieve a robust, time- and dose-dependent
reversible induction of Pm-mediated expression in mycobacteria, with low background
expression levels. XylS/Pm is thus an important addition to existing mycobacterial expres-
sion tools, especially when low basal expression is of particular importance.
Introduction
Tuberculosis (TB), caused byMycobacterium tuberculosis (Mtb), continues to be one of the
most serious lethal infectious diseases in the world. The World Health Organization reports
around 9 million new cases and 1.5 million deaths annually as a result of TB [1]. The spread of
drug-resistant mycobacteria adds to the importance of developing new anti-mycobacterial
therapies [2]. To improve TB therapeutics, it is crucial to better understand the underlying
molecular mechanisms of the disease, and to gain new insights it is important to create a
greater selection of new and enhanced molecular tools.
Inducible expression systems have become fundamental engines for genetic research. For
instance, over-expression or conditional regulation of genes enables us to map gene function,
determine gene essentiality and validate drug targets [3–5]. Regulators of inducible expression
systems can be divided into three groups; activators (positive regulation), repressors (negative
regulation) and regulators with dual activity (positive and negative regulation) [6]. Upon
induction, activators commonly lead to activation of transcription by interacting with the RNA
PLOSONE | DOI:10.1371/journal.pone.0134544 September 8, 2015 1 / 19
OPEN ACCESS
Citation: Dragset MS, Barczak AK, Kannan N, Mærk
M, Flo TH, Valla S, et al. (2015) Benzoic Acid-
Inducible Gene Expression in Mycobacteria. PLoS
ONE 10(9): e0134544. doi:10.1371/journal.
pone.0134544
Editor: Laurent Kremer, Centre National de la
Recherche Scientifique, FRANCE
Received: June 20, 2013
Accepted: July 11, 2015
Published: September 8, 2015
Copyright: © 2015 Dragset et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Funding: This work was partly supported by the
Research Council of Norway through its Centres of
Excellence funding scheme, project number 223255/
F50. In addition the Research Council of Norway
supported the work through project numbers 220836/
F10 and 246944/F10. In addition NTNU and the
Liaison Committee between the Central Norway
Regional Health Authority (RHA) and the Norwegian
University of Science and Technology (NTNU)
contributed with funding to the study.
Competing Interests: The authors have declared
that no competing interests exist.
polymerase and thereby increase the affinity between the polymerase and the promoter. Con-
versely, a repressor will typically bind to the operator sequence in the absence of inducer and
inhibit transcription initiation, for instance by preventing the binding of RNA polymerase to
the promoter. Thus, the steady state level of the repressor in the various bacterial growth phases
is important to keep basal expression low. In the presence of inducer the repressor undergoes
conformational changes, making it unable to bind the operator and thus allow transcription [6,
7]. Regulators with dual activity can act as repressors or activators of the same promoter,
depending on presence or absence of inducer [8]. While the majority of inducible expression
systems are negatively regulated, it has been proposed that positively regulated systems, inde-
pendent of repressor activity, are better candidates when tight control with low basal expres-
sion levels is desired [9, 10].
In addition to low basal expression, a good mycobacterial inducible expression system
should provide robust and reversible induction by an inexpensive, non-toxic inducer which
penetrates cells by diffusion, induce a dose- and time-dependent response and have the poten-
tial to work across mycobacterial species as well as in macrophage and animal infection
models.
While the lack of a diverse collection of mycobacterial inducible expression tools has ham-
pered research for decades, widely used inducible expression systems were developed for
Escherichia coli by the early 1980s [11, 12]. The first equivalent system in mycobacteria, the
acetamide-inducible system based on theMycobacterium smegmatis (Msmeg) endogenous
acetamidase promoter [13], was developed as late as in 1997. A few years later, a temperature-
inducible expression cassette, based on the Ptra promoter and a derivative of the TraR repres-
sor, was demonstrated to be functional but weak in mycobacteria [14]. More recently, several
tetracycline (tet) repressor-based inducible systems have been developed [15–18], together
with pristinamycin, nitril, arabinose and IPTG-inducible expression tools [19–22]. The most
recent contribution to mycobacterial inducible expression is a riboswitch-based theophylline
responsive system regulated at a translational level [23]. The aforementioned systems have var-
ious strengths and weaknesses as expression tools; all are however dependent on repression to
lower expression in the uninduced state. The nitril-inducible NitR/PnitA system adapted from
the related Gram-positive Rhodococcus rhodochrous is controlled by the AraC-family regulator
NitR proposed to work as both a repressor and activator, albeit the dual function of NitR has
not yet been experimentally verified [19, 24]. Thus, developing a positively regulated system
independent of repression of the inducible promoter could greatly benefit mycobacterial
research.
XylS/Pm is a well-studied, positively regulated expression system derived from the Pseudo-
monas putida TOL plasmid pWWO [25], and it is known to function in a wide range of Gram-
negative bacterial species [26]. The inducible Pm promoter originates from the transcriptional
regulation of themeta-cleavage pathway for benzoate and alkylbenzoate catabolism controlled
by the activator XylS and is to our knowledge fully independent of transcriptional repression in
basal expression mode [6]. Upon induction by benzoate-derived effectors, such asm-toluate,
XylS dimerizes and binds to the Pm promoter where it interacts with the transcription initia-
tion machinery and activates transcription [27, 28].
In this study we adapt XylS/Pm for use inMtb andMsmeg, introducing the first positively
regulated expression system to mycobacteria. We show robust time- and dose-dependent
inducible expression from the Pm promoter, with a basal expression comparably lower to com-
monly used mycobacterial expression tools. Importantly, by showing the function of XylS/Pm-
controlled expression in non-Gram-negative species, we demonstrate the great potential of
expanding the use of this expression system to other Gram-positive bacteria.
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Materials and Methods
Bacterial strains and culture conditions
Msmegmc2155 [29],Msmeg DM22 [30] (kindly provided by Kurt Krause, University of Otago,
New Zealand) andMtbH37Rv (ATCC 25618) were cultured in Middlebrook 7H9 (BD Difco)
supplemented with 0.2% glycerol, 0.05% Tween80 and 10% ADC (Msmeg: 50 g BSA fraction
V, 20 g dextrose, 8.5 g NaCl, 0.03 g catalase, dH2O up to 1 L) or OADC (Mtb: BD Difco). Kana-
mycin was added to 20 μg/ml in mycobacteria and to 50 μg/ml in E. coli. Hygromycin was
added to 50 μg/ml in mycobacteria. Colonies ofMsmeg were grown on LB agar plates, whereas
colonies ofMtb were grown on 7H10 (BD Difco) supplemented with glycerol and 10% OADC
(BD Difco). Standard cloning and mycobacterial transformation techniques were used.
Determination ofMtb growth inm-toluate
Strain H37Rv was grown to mid log phase in standard 7H9 media. The culture was then diluted
to an OD600 of 0.01 and aliquoted in a 96-well plate with the final concentrations ofm-toluate
as indicated in the respective figure. Ethanol carrier concentration was equal in all conditions.
Plates were incubated at 37°C for 14 days. Cultures were then resuspended well, and OD600
was determined using a Spectramax 5 (Molecular Devices).
Expression vector construction
To create the expression plasmid pMDX, a DNA fragment containing a) xylS controlled by
Pmyc1tetO promoter [16] (called Ptet in this study), b) reverse TetR#28 [31] (called reverse TetR
in this study) controlled by Psmyc promoter [16], c) Pm promoter and d) transcriptional termi-
nators strategically placed was synthesized by Genscript USA Inc (NJ, USA). The xylS and Pm
sequences were obtained from pKT1 [32]. The synthetic expression cassette described above
(GenBank accession number KT239651) was cloned into the backbone of pMV261 [33] using
NotI. pMDX-luc was created by PCR amplification of the firefly luciferase gene from pMH109
(kindly provided by Mark Hickey/David Sherman, Seattle Biomed, Seattle, WA, USA) [34, 35],
using primers LucMDX_F and LucMDX_R. pMDX-zeo was created by PCR amplification of
the zeocin resistance gene Sh ble (GenBank accession number ABW35374.1) from pER10
(unpublished data) using primers ZeoMDX_F and ZeoMDX_R. The amplified genes were
separately cloned into pMDX using the EcoRI and NdeI sites, placing the reporter genes under
control of the Pm promoter. pTET-zeo was created by PCR amplification of the zeocin gene
from pMDX-zeo using the primer pair ZeoPacIF and ZeoPstIR. The amplified gene was
cloned into the PacI and PstI sites of pUV15TetORm [16]. pMDX-hyg-alr was constructed by
amplifying the hygromycin resistance cassette fromMsmeg ΔfxbA strain [36] using primers
pMDXHyG-F-NheI and pMDXHyG-R-SpeI and clone it into NheI and SpeI restriction sites of
pMDX, before the complete alanine racemase (alr) gene was amplified fromMsmegmc2155
[29] with primers pMDXAlr-F-NdeI and pMDXAlr-R- EcoRI and cloned into NdeI and EcoRI
restriction sites of pMDX. The pTET-alr was constructed by amplifying the alanine racemase
gene from Msmeg mc2155 [29] using primers pTetOAlr-F-Pac I and pTetOAlr-R-Sbf I and
clone it into PacI and SbfI restriction sites of pTET-zeo. pMDXint and pMDXint-luc was cre-
ated by amplifying integrase and mycobacteriophage L5 attP-site from pMC1s [16] using prim-
ers pMC1_F and pMC1_R. The generated PCR product was digested with PciI and EcoRI and
cloned into the PciI and EcoRI sites of pMDX and pMDX-luc replacing pAL5000, creating
pMDXint and pMDXint-luc, respectively. pUV15TetORm and pMC1s were kindly provided
by Sabine Ehrt/Dirk Schnappinger, Weill Cornell Medical College, New York, USA. Details of
the plasmids and primer sequences can be found in Table 1 and Table 2, respectively.
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XylS/Pm induction protocol
Msmeg orMtb transformed with either pMDX (negative control), pMDX-luc, pMDX-zeo,
pMDXint, pMDXint-luc or pMH109 (positive control for luciferase assays) were grown in 7H9
with supplements and 20 μg/ml kanamycin to stationary phase, then diluted approximately
1:500 and grown to OD600 0.05–0.1 at 37°C. At this point, the samples were normalized to
identical optical densities (ODs) and induced with the indicated amount ofm-toluate (Sigma,
1 M stock solution solved in laboratory grade ethanol). For uninduced controls the same
Table 1. Plasmids used in this study.
Plasmid Properties relevant to study Source
pMDX Kanr, XylS controlled by Ptet, reverse TetR controlled by Psmyc, Pm, oriM (pAL5000), oriE (pBR322). This study
pMDX-luc pMDX derivative. Fireﬂy luciferase gene from pMH109 cloned under control of Pm. This study
pMDX-zeo pMDX derivative. Sh ble gene cloned under control of Pm. This study
pMDXint Kanr, XylS under control of Ptet, reverse TetR controlled by Psmyc, Pm, integrase, attP-site This study
pMDXint-luc pMDXint derivative, Pm controlling ﬁreﬂy luciferase gene from pMH109, integrase, attP-site. This study
pMC1s Integrase, attP-site [16]
pNBV1 Hygr, E. coli—mycobacterial shuttle vector [37]
pKT1 Kanr, XylS controlled by Ps2, ﬁreﬂy luciferase gene from Photinus pyralis controlled by Pm, oriE (RK2). [32]
pMH109 Hygr, attP-site, ﬁreﬂy luciferase gene controlled by MOP. [34, 35]
pER10 Zeor (Sh ble gene: GenBank accession number ABW35374.1) unpublished
data
pMV261 Kanr, oriM (pAL5000), oriE (pBR322). [33]
pTET-zeo Hygr, Pmyc1tetO in control of Sh ble. TetR. This study
pUV15TetORm Hygr, Kanr, Pmyc1tetO in control of GFP. Tn10 derived TetR controlled by Pimyc. oriM (pAL5000), oriE
(pBR322).
[16]
pUV15tetORm::
luciferase
Derivative of pUV15TetORm. Pmyc1tetO in control of luciferase. [38]
pMDX-hyg-alr pMDX derivative. alr gene cloned under control of Pm. Hygr added. This study
pTET-alr pTET-zeo derivative. Pmyc1tetO in control of alr. This study
Kanr: kanamycin resistance. Hygr: hygromycin resistance. Zeor: zeocin resistance.
doi:10.1371/journal.pone.0134544.t001
Table 2. Oligonucleotides used in this study.
Primer Sequence, 5’-3’
LucMDX_F AGTCATGAACATATGGAAGACGCCAAAAACAT
LucMDX_R ATCGAATTCTCTAGAATTACACGGCGATCTTTCC
ZeoMDX_F AGTCATGAACATATGGCCAAGTTGACCAGTGCCG
ZeoMDX_R ATCGAATTCTCTAGAATCAGTCCTGCTCCTCGGCCACGA
ZeoPacIF CGCATGCTTAATTAAGAAGGAGATATACATATGGCCAAGTTGACCAGTGC
ZeoPstIR CCTCCTACTGCAGCCCGGGGGAGCCATTTAAATGCTCGAATTCATCAGTCCTGCTCCTCGGCCA
pMC1_F TTGCTGATACATGTGGAACGGCAATGCTCCTGG
pMC1_R GGATCCAGCTGCAGAATTCG
pMDXHyG-F-NheI CTAGCTAGCCTGACGTTCATCCATAGT
pMDXHyG-R-SpeI CACTAGTGCGGCTTTAGCTAATTAA
pMDXAlr-F- NdeI CCATATGCAGACCACCGAGCCCATG
pMDXAlr-R- EcoRI GGAATTCTCAATCTTGTTGTCCTGCGC
pTetOAlr-F-Pac I CCTTAATTAA ATGCAGACCACCGAGCCC
pTetOAlr-R-Sbf I ATTGGTTCCTGCAGGTCAATCTTGTTGTCCTGCGC
doi:10.1371/journal.pone.0134544.t002
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amount of ethanol was added in place of inducer. The samples were incubated with shaking at
30°C or 37°C for the number of hours specified.
Mtb tetracycline-inducible luciferase comparison
MtbH37Rv containing pMDX-luc or pUV15tetORm::luciferase (a gift of Deborah Hung, The
Broad Institute [38]) was grown to mid log phase, and then diluted to an OD600 of 0.01. For
pMDX-luc strains,m-toluate or an equivalent amount of ethanol carrier was added to each
roller bottle. For pUV15tetORm::luciferase strains, anhydrous tetracycline or an equivalent
amount of water carrier was added to each roller bottle. Cultures were grown with rolling at
37°C. At the indicated time points, aliquots were taken for luciferase assays as described.
Luciferase reporter gene assays
After induction, OD600 was measured and noted. Cells were spun down at 4000 rpm for
10 minutes and pellets completely dried for any excess media before being resuspended in
100 μl dH2O. 30 μl of the resuspended cells were mixed with 7 μl 5x Passive Lysis Buffer (Pro-
mega) in the appropriate 96-well plate and incubated with shaking for 30 minutes at 37°C for
sufficient lysis. After incubation, assay substrate (Promega, E1500) was prepared according to
manufacturer’s instructions and 75 μl added to each well containing cell lysis mixture. Biolumi-
nescence was subsequently measured according to manufacturer’s recommendations on a
Fluoroskan Ascent FL (Labsystems). The relative luminescence units (RLU) were recorded and
normalized with regard to OD600 or colony forming units (CFU). To measure the amount of
luciferase produced, cell pellets from uninduced or induced cultures were resuspended in 1 ml
Passive Lysis Buffer and the cells were disrupted using 0.1 mm glass beads and an MP Fas-
tPrep-24 (3 x 45 sec, 6000 M/S). The samples were normalized by OD before cell disruption.
50 μl cell lysate was combined with 50 μl luciferase assay substrate and luciferase activity was
measured as above. The amount of luciferase produced was determined by comparison to
known luciferase concentrations (luciferase obtained from Abcam) and normalized to total
protein levels as measured by BioRad Protein Assay.
Zeor (Sh ble) gene assay
On solid media: after 5 hours pre-induction with 1.5 mMm-toluate (induced) or ethanol
(uninduced),Msmeg cultures containing were normalized by ODmeasurements and serially
diluted. The dilutions were spotted on LB agar plates with 20 μg/ml kanamycin and increasing
amounts of zeocin (Invitrogen). Induced samples were spotted on plates containing 1.5 mM
m-toluate, and uninduced samples were spotted on plates containing ethanol instead ofm-tol-
uate. The plates were incubated at 30°C for 2 days.
In liquid media: after 5 hours pre-induction with 1.5 mMm-toluate, induced and unin-
ducedMsmeg cultures were normalized to OD600 0.005 and grown in the presence of increas-
ing concentrations of zeocin and 1.5 mMm-toluate (induced) or ethanol (uninduced) in
special micro-plate “honeycomb” wells (Oy Growth Curves Ab Ltd). Growth was monitored
by Bioscreen (Oy Growth Curves Ab Ltd), registering OD600 every 2 hours. For the comparison
between pMDX-zeo and pTET-zeo, the cultures were diluted directly to OD600 0.005, without
pre-induction. The pMDX-zeo strain was grown in the presence or absence of 1.5 mMm-tolu-
ate, while the pTET-zeo strain was grown in the presence or absence of 200 ng/ml anhydro-tet-
racycline (atc, Sigma).
Benzoic-Acid Inducible Expression in Mycobacteria
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Results
Functional adaptation of XylS/Pm expression system for regulation of
gene expression in mycobacteria
Wewanted to investigate whether the Gram-negative, positive regulator system XylS/Pm could
be functional in mycobacteria. We determined that the most direct way to evaluate the induction
potential of this system would be by simply cloning the entire Gram-negative broad host range
expression cassette into a mycobacteria-E. coli shuttle vector, introducing it into mycobacteria
and assessing for inducibility. Hence, we took the XylS/Pm cassette from pKT1 [32], cloning
XylS with its native constitutive promoter and the reporter gene encoding firefly luciferase
expressed from the inducible Pm promoter, into the shuttle vector pNBV1 [37]. However, no
induction of luciferase expression was observed inMsmeg, despite optimization of induction
time, inducer concentration and growth phase. We could, on the other hand, observe low basal
expression from Pm independent of presence or absence of inducer (results not shown). Clearly,
several factors could explain the lack of induction; the inducer might be unable to diffuse through
the complex mycobacterial cell wall, XylS might not be properly expressed, the RNA polymerase
might not interact with XylS or the Pm promoter and/or the chosen reporter gene might not be
properly transcribed or translated in mycobacteria. Finally, the reporter gene product could be
toxic to the new host cell when over-produced. To unravel potential obstacles, we tested whether
the inducer could enter the cell, hypothesizing that increased concentrations of inducer would
be toxic if successfully entering the bacteria.Msmeg was grown in the presence of increasing
amounts ofm-toluate, and indeed, we saw increasing toxicity proportional to increasing inducer
concentration (S1 Fig indicating that the inducer enters the cells.
We then changed the native promoter driving expression of xylS to a mycobacterial pro-
moter, ensuring proper constitutive expression of the activator. We chose the Pmyc1tetO pro-
moter (called Ptet in our study) from Ehrt et al.’s adapted tet-inducible system, based on its
constitutive function in the absence of the TetR repressor [16]. Excess of XylS has previously
been shown to stimulate expression from Pm in the absence of inducer [28, 39, 40]. To over-
come the potential increase in background expression due to over-production of XylS, we
introduced a mechanism for turning off xylS transcription by adding a mutant version of TetR
to our construct. In contrast to standard TetR, the mutant acts as a reverse repressor, binding
rather than releasing the operators in Ptet upon tetracycline induction (TetR#28 from [31]). In
the event of high basal expression due to excessive XylS, we could tune down XylS production
by adding anhydro-tetracycline (atc) to the media, facilitating tighter regulatory control and
lower levels of basal expression.
To address the possibility of luciferase reporter toxicity to our cells, the firefly luciferase
reporter gene was changed from wild type to a modified version of the firefly luciferase previ-
ously shown to be functional in mycobacteria [34, 35]. As presented in Fig 1, the adapted XylS/
Pm expression system is in an OFF mode at baseline (no induced transcription from Pm) in
the absence of the inducerm-toluate (Fig 1, middle panel). However, to potentially further
minimize background expression, atc can be added to repress xylS transcription, leaving the
system in a more fully OFF mode (Fig 1, lower panel). Transcription from Pm is fully ON in
the presence ofm-toluate and in the absence of tetracycline (Fig 1, upper panel).
Induction of Pm withm-toluate is robust, time- and dose-dependent in
mycobacteria
Following modification of the XylS/Pm expression cassette, we examined whether gene expres-
sion could, in fact, be induced in mycobacteria by addition ofm-toluate. We introduced our
Benzoic-Acid Inducible Expression in Mycobacteria
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adapted expression system with luciferase as a reporter gene (pMDX-luc) toMsmeg, and by
optimizing inducer concentration and induction time we were able to achieve robust induction.
When adding 1.5 mMm-toluate, we reached up to 90-fold induction (ratio of induced to unin-
duced expression levels) during late log phase (Fig 2A and 2B). Furthermore, we demonstrated
that induction was time-dependent, peaking after 24 hours, and dose-dependent, rising nearly
proportionally with increased inducer concentrations. In contrast, uninduced background lev-
els of luciferase did not increase over time (Fig 2A and 2C). Normalizing luciferase expression
to CFU instead of OD600 gave an enhanced induction pattern after 24 hours; we reached
240-fold induction by CFU normalization (S2 Fig).
The amount of luciferase expressed was determined by measuring relative luminesecence
units, RLUs, which are relative. To get a sense of expression from Pm relative to other standard
mycobacterial promoters, we compared our induced levels of luciferase with the stably
expressed levels from the strong constitutive mycobacterial optimal promoter, MOP [35]. We
transformedMsmeg with pMH109, an integrative plasmid containing our luciferase gene
under control of MOP [35]. As seen in Fig 2D, when Pm was induced with 2 mMm-toluate,
luciferase expression exceeded the level expressed fromMOP, indicating that a high level of
expression can be achieved using XylS/Pm. Furthermore, to approximate the amount of lucifer-
ase produced, sample luciferase activity was compared to the activity of known luciferase con-
centrations. Fig 2E and 2F show the level of luciferase produced for uninduced and induced
samples at mid log and stationary phase, respectively. When normalized to the total protein
Fig 1. Benzoic acid-inducible expression system, XylS/Pm, for regulation of genes in mycobacteria. The inducible Pm promoter and its activator XylS
regulate the expression of “your favorite gene” (YFG). XylS is constitutively expressed under control of Ptet in the absence of anhydro-tetracycline (atc) and
binds the Pm promoter in the presence of the inducerm-toluate. This facilitates expression of YFG and leaves the expression system ON (upper panel). In
the absence ofm-toluate, XylS is not activated, leaving the expression system OFF, as expression from Pm is not induced (middle panel). Reverse TetR is
constitutively expressed by Psmyc, and binds the operator in Ptet in the presence of atc blocking transcription of xylS. Addition of atc leaves the system in a
more fully OFF mode as potential basal Pm-mediated transcription caused by excessive levels of XylS is abolished (lower panel).
doi:10.1371/journal.pone.0134544.g001
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concentration of the lysed cell samples, the amount of luciferase constituted approximately
0.022% (0.1 μg/ml luciferase) and 0.003% (0.012 μg/ml luciferase) of total protein in uninduced
samples in mid log and stationary phase, respectively. Induced samples contained 0.11% (mid
log, 0.64 μg/ml) and 0.096% (stationary, 0.38 μg/ml) luciferase.
Our pMDX-luc plasmid is episomal (pAL5000 ori) with an estimated copy number of
3–10 in mycobacteria [41]. To determine whether we could also induce expression from a
chromosomally integrated single copy of the XylS/Pm expression cassette, we constructed
pMDXint-luc, a vector integrating at the mycobacteriophage L5 attachment site. Again using
luciferase as the reporter gene, we induced pMDXint-luc-transformedMsmeg alongside our
Msmeg pMDX-luc strain, demonstrating inducible expression (~10-fold induction) even when
the expression system was chromosomally integrated (S3 Fig).
Our initialMsmeg induction experiments presented in Fig 2A–2D were carried out at 30°C,
based on favorable conditions for soluble recombinant protein production in Gram-negatives
[42] and standard protocols for XylS/Pm expression in Gram-negatives [43]. Although our
adapted version of XylS/Pm works well inMsmeg at 30°C, we wanted to compare induction at
different temperatures to determine the system’s utility in standard conditions used for myco-
bacterial experiments. Hence, we induced ourMsmeg pMDX-luc strain with different concen-
trations ofm-toluate and incubated the samples at either 30°C or 37°C during induction. Pm
was clearly induced at 37°C, reaching even higher induction ratios than at 30°C (S4 Fig).
After optimizing induction inMsmeg, we turned toMtb to see if we could induce expression
through Pm in a comparable fashion in the pathogenic species. pMDX-luc-transformedMtb
Fig 2. Induction of Pmwithm-toluate is robust, time- and dose-dependent.Msmeg transformed with the expression vectors pMDX-luc or the empty
vector pMDX (no reporter gene) treated with increasing concentrations ofm-toluate (induced) or ethanol carrier (uninduced). Cells were incubated at 30°C,
and luciferase expression was determined at 2.5, 5.5, 11, 23, 31 and 49 hours after addition ofm-toluate. (A) Fold induction of RLU in induced samples
compared to uninduced samples. (B) Growth of uninduced and induced samples of pMDX-luc corresponding to samples in (A). (C) Time course of luciferase
induction from pMDX-luc with 1.5 mMm-toluate or ethanol carrier. (D) Maximal induction of pMH109 and pMDX-luc-transformedMsmeg induced with 2 mM
m-toluate. (E) Amount of luciferase produced as determined by the activity of known luciferase concentrations (0, 0.1, 0.2, 0.4 0.6, 0.8 and 1 μg/ml luciferase)
in mid log phase or (F) stationary phase. Luciferase fraction of total bacterial protein shown in brackets. RLUs were normalized to the OD600 of the samples
before luciferase assay. All results are representative of two or more independent experiments.
doi:10.1371/journal.pone.0134544.g002
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was induced in a similar manner as described forMsmeg. As shown in Fig 3A, the Pm pro-
moter was clearly inducible inMtb, and showed a time-dependent response peaking in late log
phase. Maximum induced expression was overall lower inMtb than inMsmeg (Fig 3A and 3B).
Mtb showed a similar tolerance pattern towardsm-toluate asMsmeg (S1 Fig). Taken together,
Fig 3. Induction of Pm inMtb.Mtb transformed with the expression vector pMDX-luc or the empty vector
pMDX were induced with indicated concentrations ofm-toluate (induced), or ethanol carrier (uninduced).
Samples were maintained rolling at 37°C and analyzed for luciferase expression levels at 2, 3, 4 and 6 days
after induction. (A) Fold induction of RLU of induced to uninduced samples normalized for OD600. (B) Growth
of uninduced and induced samples containing pMDX-luc corresponding to samples in (A). The results are
representative for two independent experiments.
doi:10.1371/journal.pone.0134544.g003
Benzoic-Acid Inducible Expression in Mycobacteria
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our results show that we are able to achieve a robust, time- and dose-dependent induction of
the Pm-promoter in mycobacteria.
Addition of anhydro-tetracycline restricts Pm-mediated induction through
inhibition of xylS expression
Positively regulated expression systems are proposed to have lower basal transcription rates
than negatively regulated systems [9, 10]. We wanted to investigate whether repressing XylS
production would decrease the basal expression from Pm even further. First, to confirm that
adding anhydro-tetracycline (atc) to the media would activate the reverse TetR to bind the
operator and reduce transcription of the xylS gene, we incubated ourMsmeg pMDX-luc strain
with or without 100 ng/ml atc over night, thus giving TetR time to bind and inhibit Ptet-con-
trolled xylS-transcription. Aside from addition of atc, the samples were treated identically, and
induced to maximum expression of luciferase (Fig 4A). We could clearly see that the addition
of atc markedly reduced expression of luciferase from the Pm promoter, most likely due to the
lack of activator in the cells. However, inhibiting xylS expression by atc did not seem to further
lower the basal expression from Pm (Fig 4A), suggesting that background expression is likely
to be mediated byMsmeg endogenous transcription machinery rather than excessive XylS
production.
Induced expression from Pm can be reversed by inducer washout
Mapping gene function and essentiality are important aspects of mycobacterial research. To
investigate phenotypes arising from very low expression levels of the genes of interest, being
able to reverse induced expression is crucial. To investigate whether removing the inducer by
washout could reduce expression from Pm in mycobacteria, we induced ourMsmeg pMDX-luc
strain to maximum luciferase expression (about 90-fold, results not shown) before washing the
cells in inducer-free media upon subcultivation or directly subcultivation without washing.
When the subcultures reached late log phase, we measured luciferase activity (Fig 4B). After
Fig 4. Induced expression from Pm is reversible. (A)Msmeg transformed with pMDX-luc were grown to OD600 0.05–0.1 in the presence of anhydro-
tetracycline (+ atc), or in the absence of atc. Cells were then induced with 1.5 mMm-toluate for 24 hours and grown with shaking at 30°C before RLU was
measured.Msmegwild type was included as negative control. Error bars represent standard deviations. (B)Msmeg pMDX-luc was induced to maximum fold
induction (~90 fold—not shown). Cells were then either washed once in 7H9 (wash), or left untreated (no wash) before diluted to OD600 0.05–0.1. Washed
samples were grown to late log phase in the presence (+ atc) or absence of atc. Unwashed samples were grown to late log phase in the absence of atc. Cells
transformed with pMDX (empty vector) were included as negative control. RLUs were normalized by OD600. The results are representative for two or more
independent experiments.
doi:10.1371/journal.pone.0134544.g004
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subcultivation, only the unwashed sample showed induction (about 40 fold), demonstrating
that inducer washout before re-cultivation is enough to completely return the cells to an unin-
duced state.
We furthermore investigated whether a combination of inducer washout and addition of atc
to turn off xylS expression would lower the basal Pm expression. We added 100 ng/ml atc to
washed cells upon subcultivation, and allowed them grow to late log phase in the presence of
atc before measuring luciferase. Compared with wash alone, no further decrease in background
expression levels was observed in the presence of atc (Fig 4B). Together, our results demon-
strate that we could successfully revert to uninduced levels of expression by inducer washout
prior to subcultivation.
Regulation of the zeocin resistance gene (Sh ble) by XylS/Pm
After demonstrating that we could induce gene expression via Pm in a precisely controlled
fashion, we wanted to investigate whether Pm could be used for conditional regulation of bio-
logically active genes in mycobacteria. Zeocin is an antibiotic of the bleomycin/phleomycin
family that causes cell death by cleaving DNA. Resistance to zeocin is conferred by the Sh ble
gene encoding a small acidic protein, which inhibits the antibiotic by binding to it in a stoichio-
metric manner [44]. By taking advantage of these properties we can mimic the regulation of a
conditional essential gene in mycobacteria, making the Sh ble gene essential for survival in the
presence of zeocin. Hence, the Sh ble gene was cloned under control of XylS/Pm, creating
pMDX-zeo.Msmeg transformed with pMDX-zeo was induced for 5 hours to give the Sh ble
gene a chance to be expressed at low levels. The culture was then serially diluted and spotted
on agar plates containing bothm-toluate and increasing concentrations of zeocin (Fig 5A);
plates were then incubated for 48 hours. Uninduced controls were included in the experiment
by simultaneous spotting on plates lackingm-toluate. As shown in Fig 5A, the initial number
of bacteria seen on the uninduced and induced plates were identical (compare uninduced and
induced samples, 0 μg/ml zeocin). However, induced cells could survive concentrations of zeo-
cin up to 100–200 μg/ml due to the elevated production of the conditionally essential Sh ble
gene product; a few small colonies were still visible in induced sample at the 200 μg/ml concen-
tration. Moreover, the smaller colony sizes seen in the uninduced sample in the presence of
zeocin concentrations as low as 1 μg/ml suggest that the uninduced cells have limited ability to
grow under even low levels of zeocin stress (Fig 5A).
To get a more detailed picture of the zeocin-mediated growth inhibition, we diluted pre-
induced cultures ofMsmeg pMDX-zeo in increasing concentrations of zeocin with or without
m-toluate. OD600 was measured every two hours over a 48 hour period, and the absorbance
measured for cells grown in increasing zeocin concentrations was determined at the time point
the sample, induced or uninduced, grown in absence of zeocin had reached mid log phase
(Fig 5B). Uninduced sample showed a significantly reduced growth rate in zeocin concentra-
tions as low as 1 μg/ml, and growth was nearly completely inhibited at 2.5 μg/ml. Induced sam-
ples grew close to normally with up to 15 μg/ml zeocin before the growth rate was gradually
reduced. Controls with empty vector lacking Sh ble grew only in media without zeocin (results
not shown). These results show that the XylS/Pm expression system could serve as a tool to reg-
ulate conditionally essential genes in mycobacteria.
Pm compares favorably to Ptet in basal expression levels inMsmeg
So far, we have established XylS/Pm as a functional expression tool inMsmeg andMtb, and
demonstrated that it is a potential tool for conditional control of essential genes in mycobacte-
ria. We wanted to investigate next how XylS/Pm compared to a commonly used inducible
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mycobacterial expression tool, with emphasis on basal expression levels. We cloned the Sh ble
gene conferring resistance to zeocin under control of Ptet in pUV15TetORm (Tn10-derived
TetR controlled by the intermediate strong promoter Pimyc and pAL5000 mycobacterial ori)
[16] for direct comparison to XylS/Pm, creating pTET-zeo. The Pm and Ptet-regulated systems
were introduced toMsmeg, induced and monitored for 120 hours in increasing concentrations
of zeocin (S5 Fig).
Pm and Ptet-mediated basal expression was compared through determination of the
amount of zeocin tolerated by the uninduced expression strains in log phase or stationary
phase. While we observed comparable sensitivity to increasing concentrations of zeocin in
uninduced Pm and Ptet-regulated strains in log phase (Fig 6A), the Ptet-regulated strain could
grow in the presence of higher concentrations of zeocin than the Pm-regulated strain in sta-
tionary phase in the absence of inducer (Fig 6B). The pMDX-zeo strain was severely growth
restricted in the presence of as little as 5 μg/ml zeocin, whereas the pTET-zeo strain could toler-
ate up to 250 μg/ml zeocin before reaching the same level of growth inhibition in stationary
phase (Fig 6B). These results suggest that basal expression from Ptet generates significantly
higher levels of Sh ble transcripts than Pm during prolonged growth.
Comparison of induced samples of pMDX-zeo and pTET-zeo revealed higher levels of Sh
ble expression in Ptet than Pm-regulated cells. pTET-zeo cultures grew nearly unaffected by the
Fig 5. Regulation of the zeocin resistance gene in the presence of zeocin. (A)Msmeg transformed with pMDX-zeo was grown to OD600 0.05–0.1 before
addition of 1.5 mMm-toluate (induced) or ethanol carrier (uninduced) was added. Cells were then incubated for 5 hours at 30°C. The cells were normalized
by OD600, serially diluted, and spotted on plates containing increasing amounts of zeocin and 1.5 mMm-toluate (induced) or ethanol (uninduced) and
incubated at 30°C for 2 days. (B)Msmeg transformed with pMDX-zeo was pre-induced for 5 hours as described above, then diluted to OD600 0.005 and
grown in triplicates in micro-plate wells in the presence of increasing concentrations of zeocin (0, 0.5, 2.5, 5, 7.5, 10, 15, 25, 50, 100, 150, 200 and 250 μg/ml)
and 1.5 mMm-toluate (induced) or ethanol carrier (uninduced) shaking at 37°C. Growth was monitored by Bioscreen, registering OD600 every other hour.
The samples are presented by the OD600 of uninduced or inducedMsmeg pMDX-zeo in increasing concentrations of zeocin, when the respective sample
grown in the absence of zeocin reached mid log phase. Error bars represent standard deviations and the results represent three independent experiments.
doi:10.1371/journal.pone.0134544.g005
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antibiotic up to 50 μg/ml zeocin in mid log phase (under optimized conditions for tet-inducible
expression [16]) (Fig 6D), while growth of pMDX-zeo cultures was markedly inhibited by
10 μg/ml zeocin under optimized conditions (Fig 6C). Overall, Ptet-regulated cells showed
around 10-fold higher induced levels of the zeocin resistance protein compared to Pm.
Although Pm drives lower levels of basal expression than commonly used inducible pro-
moter systems during extended growth, Pm-mediated background expression might still be of
biological relevance. In S6 Fig we cloned the alanine racemase gene (alr), which gene product
catalyzes the conversion of L-alanine to D-alanine, under the control of XylS/Pm. For this par-
ticular gene, the background levels of alr expression were sufficient forMsmeg to produce
enough D-alanine for normal growth. The same was seen for Ptet-regulated alr expression, and
similar results were obtained for both Ptet and Pm-regulated alr expression on solid (S6 Fig)
and liquid media (results not shown). These results underline that successful regulation of con-
ditionally essential genes using inducible expression systems depends largely on the gene in
question.
Fig 6. Pm–mediated basal expression is low and compares favorably to Ptet-mediated basal expression inMsmeg. (A-B)Msmeg transformed with
pMDX-zeo or pTET-zeo was diluted to OD600 0.005 in the presence or absence of m-toluate (1.5 mM) or atc (200 ng/ml), respectively, and increasing
amounts of zeocin (0, 0.5, 2.5, 5, 7.5, 10, 15, 25, 50, 100, 150, 200, 250 or 500 μg/ml). Samples were grown in triplicates and monitored for 120 hours by a
Bioscreen, registering OD600 every other hour. Basal expression from Pm and Ptet is presented by growth ofMsmeg pMDX-zeo andMsmeg pTET-zeo in
increasing concentrations of zeocin, when the respective sample grown in the absence of zeocin reached mid log phase (A) or stationary phase (B). (C)
Induced and uninduced samples of pMDX-zeo strain in late log phase. (D) Induced and uninduced samples of pTET-zeo strain in mid log phase. The results
represent two independent experiments.
doi:10.1371/journal.pone.0134544.g006
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Pm compares favorably to Ptet in basal expression levels inMtb
The behavior of Pm inMtb was investigated by transformation of pMDX-luc or pUV15te-
tORm::luciferase, and comparing Pm and Ptet-mediated basal expression through determina-
tion of the levels of luciferase produced by the two strains under induced and uninduced
conditions. As seen for Sh ble, pUV15tetORm::luciferase revealed higher levels of luciferase
expression compared to Pm-regulated cells during exponential growth (Fig 7A). We measured
luciferase activity in the uninduced samples and we observed a background expression from
Pm that was low throughout the experiment. For pUV15tetORm::luciferase we observed an
increase in background expression over time (Fig 7B).
Taken together, our results indicate thatMtb basal expression mediated by Pm is signifi-
cantly lower than Ptet basal expression, under the given conditions. While Ptet-regulated con-
structs result in higher induction, XylS/Pmmay provide an advantage for experiments where
consistent low background expression is of particular importance.
Discussion
In this study we have successfully introduced a benzoic acid-inducible expression system to
mycobacteria, and expanded the repertoire of mycobacterial tools for studying gene function
and essentiality. XylS/Pm has previously been thoroughly studied and applied in Gram-nega-
tives (reviewed in [6]). Importantly, by adapting Pm-regulated expression to mycobacteria, we
demonstrate for the first time the great potential of expanding the use of this expression system
to non-Gram-negative species.
Upon induction withm-toluate, we show a typical 90-fold increase for Pm-mediated
reporter gene expression inMsmeg (Fig 2A), an induction ratio comparable to or higher than
the reported ratios of all other published inducible mycobacterial expression systems based on
reporter gene assays [15–19, 21, 23]. The exception is the pristamycin-inducible system with a
reported 400-fold induction inM. tuberculosis [21]. We also report a dose-dependent response,
with higher concentrations of inducer leading to increased induction ratios (Fig 2A). Although
we might reach even greater expression levels by further increasing inducer concentrations,
Fig 7. Pm–mediated basal expression is low and compares favorably to Ptet-mediated basal expression inMtb. (A-B)Mtb transformed with pMDX-
luc or pUV15tetORm::luciferase was diluted to OD600 0.005 in the presence or absence of m-toluate (1.5 mM) or atc (200 ng/ml), respectively. Samples were
grown in triplicates and monitored for 7 days registering OD600 at 2, 4 and 7 days. Basal expression from Pm and Ptet is presented by level of luciferase
produced byMtb pMDX-luc andMtb pUV15tetORm::luciferase. (A) shows the luciferase expression over time in induced sample and (B) shows the basal
expression from uninduced samples over time. The results represent two independent experiments.
doi:10.1371/journal.pone.0134544.g007
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due to a decrease in growth rate in the presence of more than ~1.5 mMm-toluate (S1 Fig) we
chose to largely avoid concentrations above 1.5 mM. Furthermore, in this study we focused on
one of many XylS/Pm-inducers known to work in Gram-negative bacteria [45]. Other inducers
might compare favorably tom-toluate when it comes to both inducibility and toxicity in
mycobacteria.
While Pm-mediated expression clearly functions inMtb, we are not able to reach the same
level of induced expression as inMsmeg, and we do not see the same dose-dependent response
(Fig 3A). Nevertheless, as inMsmeg, we see a time-dependent response, with a peak in expres-
sion in late log phase (Fig 3A and 3B). The ~10-fold increase in induction observed using 0.15
mMm-toluate is comparable to the 0.15 mM-induction ofMsmeg, but increasing inducer con-
centration further does not boost expression inMtb. Mycobacterial drug efflux pumps have
been identified inMtb for inducers like tetracycline [46, 47], and we cannot exclude similar
active pumping ofm-toluate out of the cell, resulting in a decreased maximal response to
induction. Alternatively,m-toluate could be metabolized by mycobacteria, decreasing the con-
centration of inducer in the cell, as oxidation of benzoate and related substances was reported
in early mycobacterial research [48]. Another inducer might thus be superior tom-toluate for
XylS/Pm-induction inMtb.
XylS/Pm can be suitable to regulate conditionally essential genes in mycobacteria. We
cloned the Sh ble gene, which confers zeocin resistance, under the control of Pm (pMDX-zeo)
inMsmeg. Our results demonstrated that induced cells containing pMDX-zeo survived signifi-
cantly better in the presence of zeocin than uninduced cells, with growth of uninduced cells
inhibited by as little as 1 μg/ml zeocin (Fig 5). Although the growth rate of uninduced cells that
carry the resistance gene showed inhibition at 1 μg/ml zeocin, cultures did grow, albeit slowly,
in the presence of up to 5–10 μg/ml of the antibiotic. In contrast, cells transformed with a vec-
tor lacking Sh ble, did not grow at 0.5 μg/ml zeocin (results not shown). This observation sug-
gests that the uninduced basal expression of the resistance gene is appreciably low, but might
be biologically relevant depending on the gene in question. When we controlled expression of
the alanine racemase gene with the Pm and Ptet promoters, we observed that background
expression of the conditionally essential gene was sufficient to maintain a wild type phenotype.
Comparing Pm-mediated background expression with the background expression of the
widely used tet-inducible Ptet-promoter [16], Pm in fact drives lower levels of basal expression
than Ptet both inMsmeg andMtb (Figs 6B and 7B). Here, Ptet basal expression level (unlike
Pm) is dependent on active repression of transcription. A codon usage adaption of the Tn10-
derived TetR for optimal gene regulation inMtb resulted in 3-fold improved repression in
Msmeg when the repressor was expressed episomally, due to increased TetR steady state levels
[31]. It is plausible that the increase in Ptet-mediated background expression we observed in
stationary phase is due to a decrease in TetR steady state levels during prolonged growth, mak-
ing the repressor-independent nature of Pm-mediated basal levels a likely explanation for the
lower background expression seen in XylS/Pm. Reverse gene regulation tools, where the addi-
tion of the effector molecule turns transcription off instead of on, have been developed to
silence genes in mycobacteria [31, 49, 50]. This approach has proved useful to study condi-
tional mutants [50, 51], however, these systems are still dependent on sufficient expression of
the repressor to keep the gene expression low. In our system, the consistent low basal expres-
sion coupled to titratable, strong induction makes Pm an appealing option for regulated gene
expression in mycobacteria, and XylS/Pmmay be a particularly good alternative when a consis-
tent, low background expression is important.
Basal rates of Pm-regulated expression were not reduced by addition of atc, which suggests
that the XylS production is unlikely to be high enough to drive transcription from the unin-
duced construct. Instead, the low background expression observed in our experiments is most
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probably due to leaky transcription from the Pm promoter itself initiated at a low rate by the
endogenous transcription machinery. Consequently, future work toward even tighter control
of Pm basal transcription in mycobacteria would include random mutagenesis of the promoter
or the 5’ untranslated region, which previously has been shown to improve XylS/Pm-mediated
regulation in E. coli [43, 52].
An important aspect of mycobacterial research is the modulation of gene expression during
infection. Tet-inducible expression systems are thus far the only tools for induction in macro-
phage or animal models of mycobacterial infection [15, 16, 18]. The XylS/Pm-inducers are
weak acids passively diffusing through plasma membranes. Medina et al. successfully induced
expression of dTomato reporter protein under the control of the Pm promoter in Salmonella
during the infection of HeLa cells, using salicylate as inducer [53]. These results support the
potential function of our adapted XylS/Pm expression system during mycobacterial infections
of macrophages. Benzoic acid is commonly used as a food preservative [54, 55], which together
with the fact that benzoic acids can readily diffuse across plasma membranes suggests that
inducers of Pm-mediated expression could be excellent candidates for oral administration in
animal models. Thus, XylS/Pm has potential to become the second inducible regulator of
mycobacterial expression applicable in animal models of tuberculosis.
Supporting Information
S1 Fig. Growth curves in the presence of m-toluate. (A)Msmeg and (B)Mtb grown in 7H9
medium with increasing concentrations ofm-toluate. OD600 was determined after 2.5, 5, 8, 10
and 24 hours (Msmeg), or 4, 10 and 14 days (Mtb).
(TIF)
S2 Fig. Induced luciferase expression normalized to OD600 and RLU.Msmeg transformed
with pMDX or pMDX-luc was grown to stationary phase, subcultured and grown to OD600
0.05–0.1 before induction by 1.5 mMm-toluate (induced) or ethanol carrier (uninduced). Cul-
tures were incubated for 24 hours with shaking at 37°C before luciferase expression was mea-
sured. RLU was normalized to (A) OD600 or (B) CFU, reaching 110 and 240-fold induction,
respectively.
(TIF)
S3 Fig. XylS/Pm is inducible when integrated in the chromosome.Msmeg transformed with
pMDXint, pMDXint-luc or pMDX-luc were grown to stationary phase, subcultured and grown
to OD600 0.05–0.1 before addition of 1.5 mMm-toluate (induced) or ethanol carrier (unin-
duced). Cultures were incubated for 24 hours with shaking at 30°C before luciferase expression
was measured. Results are presented as RLU normalized to OD600. Results are representative
for three individual experiments.
(TIF)
S4 Fig. Induction of Pm is robust at both 30 and 37°C.Msmeg transformed with pMDX-luc
was grown to stationary phase, subcultured and grown to OD600 0.05–0.1 before addition of
0.05, 0.25, 1 or 1.5 mMm-toluate (induced) or ethanol carrier (uninduced). Cultures were
incubated for 24 hours with shaking at 30 or 37°C before luciferase expression was measured.
Results are presented as fold induction of RLU normalized to OD600 of induced compared to
uninduced samples. The fold inductions of RLUs comparing 30°C and 37°C were obtained in
separate luciferase assays. Results are representative for two or more independent experiments.
(TIF)
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S5 Fig. Comparison of Ptet and Pm-mediated expression.Msmeg containing pTET-zeo or
pMDX-zeo was grown to stationary phase, then diluted to OD600 0.005 in the presence or
absence of inducer. pMDX-zeo was induced with 1.5 mMm-toluate, and pTET-zeo was
induced with 200 ng/ml anhydro-tetracycline (atc). The samples were grown in triplicates in
micro-plate wells in increasing amounts of zeocin (0, 0.5, 2.5, 5, 7.5, 10, 15, 25, 50, 100, 150,
200, 250 or 500 μg/ml). Growth was monitored for 120 hours using a Bioscreen, shaking at
37°C, registering OD600 every other hour. All growth curves represent the average of 3 repli-
cates.
(TIF)
S6 Fig. Alanine racemase gene controlled by Pm and Ptet.Msmeg wt, DM22 mutant and
DM22 containing pTET-alr or pMDX-hyg-alr were grown to stationary phase then serial
diluted and spotted onto agar plates with or without D-alanine.
(TIFF)
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